BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12907499)

  • 1. No more free lunches: it is time to own up.
    Fitzpatrick C
    BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907499
    [No Abstract]   [Full Text] [Related]  

  • 2. No more free lunches: it is time we all grew up.
    Wessely S
    BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907497
    [No Abstract]   [Full Text] [Related]  

  • 3. No more free lunches: doctors and journals in the South cut off drug companies at their peril.
    Ana J
    BMJ; 2003 Aug; 327(7410):341-2. PubMed ID: 12907496
    [No Abstract]   [Full Text] [Related]  

  • 4. No more free lunches: how to dance with porcupines.
    Rudolphy S
    BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907495
    [No Abstract]   [Full Text] [Related]  

  • 5. No more free lunches: the market has us all in its grip.
    Madhavan KS
    BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907501
    [No Abstract]   [Full Text] [Related]  

  • 6. No more free lunches: relationship between industry and research does not bear scrutiny.
    Myr R
    BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907498
    [No Abstract]   [Full Text] [Related]  

  • 7. Australian regulator insists on greater transparency of industry payments to doctors.
    Coopes A
    BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811
    [No Abstract]   [Full Text] [Related]  

  • 8. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 9. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 10. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations.
    Rosenbaum L
    N Engl J Med; 2015 May; 372(19):1860-4. PubMed ID: 25946288
    [No Abstract]   [Full Text] [Related]  

  • 12. No more free lunches.
    Abbasi K; Smith R
    BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflicts of Interest.
    Strandberg TE
    N Engl J Med; 2015 Aug; 373(8):779. PubMed ID: 26287865
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflicts of Interest.
    Fleischman W; Newman DH
    N Engl J Med; 2015 Aug; 373(8):778-9. PubMed ID: 26287864
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflicts of Interest.
    Roper N
    N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287863
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflicts of Interest.
    Abramson J; Redberg R
    N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287862
    [No Abstract]   [Full Text] [Related]  

  • 17. Conflicts of Interest.
    Rosenbaum L
    N Engl J Med; 2015 Aug; 373(8):779-80. PubMed ID: 26287861
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicians and the drug industry. "To be like that, you'd better be married."].
    Peiró S
    Rev Calid Asist; 2009 Apr; 24(2):47-50. PubMed ID: 19426926
    [No Abstract]   [Full Text] [Related]  

  • 19. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.